AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
22.56
+1.66 (7.94%)
At close: May 29, 2025, 4:00 PM
22.55
-0.01 (-0.04%)
After-hours: May 29, 2025, 6:30 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for AnaptysBio stock ranges from a low of $20 to a high of $90. The average analyst price target of $42.25 forecasts a 87.28% increase in the stock price over the next year.
Price Target: $42.25 (+87.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
Buy | 5 | 5 | 6 | 5 | 5 | 5 |
Hold | 4 | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 12 | 10 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $54 → $90 | Strong Buy | Maintains | $54 → $90 | +298.94% | May 28, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $52 → $54 | Strong Buy | Maintains | $52 → $54 | +139.36% | May 6, 2025 |
Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +77.30% | May 1, 2025 |
JP Morgan | JP Morgan | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +86.17% | Mar 5, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $22 | Hold | Reiterates | $22 | -2.48% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
55.97M
from 91.28M
Decreased by -38.68%
Revenue Next Year
61.42M
from 55.97M
Increased by 9.72%
EPS This Year
-5.31
from -5.12
EPS Next Year
-4.96
from -5.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 149.7M | 216.3M | 152.3M | ||
Avg | 56.0M | 61.4M | 66.1M | ||
Low | 11.8M | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 64.0% | 286.4% | 147.9% | ||
Avg | -38.7% | 9.7% | 7.7% | ||
Low | -87.1% | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.09 | -1.56 | -3.02 | ||
Avg | -5.31 | -4.96 | -5.66 | ||
Low | -6.56 | -6.76 | -9.76 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.